The Prevalence and the significance of the Pulmonary Bacterial Super-Infections among Hospitalized COVID-19 patients : A scoping Review
DOI:
https://doi.org/10.32792/utq/utjsci/v10i1.930Keywords:
bacterial superinfection, Prevalence, COVID-19, Hositalized patients.Abstract
Mortality of any respiratory viral diseases usually attributed in part to other reasonse than damaging effect of the virus alone. One of these reasons is the bacterial superinfection. For this reason, this scoping review attamt to evaluate the significant conterbution of bacterial super-infection on the mortality among hospitalized COVID-19 patients and also to determine the true revalence of bacterial super-infections in that population. Accordingly, a systematic search was employed with precise criteria on the MEDLINE, SCOPUS, PUBMED, and GOOGLE SCHOLAR databases published in the English language in the period of three years from January 2020 to January 2023. The Prevalence of bacterial super-infection (BSI) among COVID-19 patients constitutes a point of contention among publications. this heterogeneity among publications came from the semantic dilemma of co-infection and super-infection. co-infection was determined to be found in a relatively narrow range (1.2-3.1%) while, Prevalence of bacterial super-infection among COVID-19 patients varied from 18.2 to 50%. The bacterial super-infection appears to significantly increase COVID-19 mortality, with the Odd ratio ranging from 1.76 to 10.53 [CI 95%]. Bacterial super-infection among hospitalized COVID-19 patients represents a non-recognized threat, especially during the first wave of the pandemic. The Prevalence of bacterial super-infection is comparable with those observed in previous influenza and SARS epidemics. A significant contribution of bacterial super-infection, especially the pulmonary to mortality of COVID-19 patients, was observed clearly
References
World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report – 51 [Internet]. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrobial Resistance and Infection Control. 2020;9(1):1–7.
Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi H ali abraham, Jeda AS, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72(10):2097–111.
Esper FP, Spahlinger T ZL. Rate and influence of respiratory virus coinfection on pandemic (H1N1) influenza disease. J Infect. 2011;63:260–6.
Pozo JLD. Respiratory co-and super-infections in covid-19. Revista Espanola de Quimioterapia. 2021;34:69–71.
Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Current Opinion in Infectious Diseases. 2004;17(3):185–91.
Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest [Internet]. 2011;139(3):555–63. Available from: https://doi.org/10.1378/chest.10-1396
Morris DE, Cleary DW CS. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8(1041).
Yap FHY, Gomersall CD, Fung KSC, Ho PL, Ho OM, Lam PKN, et al. increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clinical Infectious Diseases. 2004;39(4):511–6.
Chibabhai V, Duse AG, Perovic O, Richards GA. The collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programs? South African Medical Journal. 2020;110(7):572–3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet [Internet]. 2020;395(10229):1054–62. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30566-3
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
United States M 2009. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. 2009;58(38):1071–4.
Weinberger DM, Simonsen L, Jordan R, Steiner C, Miller M VC. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis. 2012;205(3):458–65.
Huttner BD, Catho G, Pano-Pardo JR, Pulcini C, Schouten J. COVID-19: don't neglect antimicrobial stewardship principles! Clinical Microbiology and Infection [Internet]. 2020;26(7):808–10. Available from: https://doi.org/10.1016/j.cmi.2020.04.024
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection [Internet]. 2020;26(12):1622–9. Available from: https://doi.org/10.1016/j.cmi.2020.07.016
Lansbury L, Lim B, Baskaran V, Lim WS. Co-Infections in People with COVID-19: A Systematic Review and Meta-Analysis. SSRN Electronic Journal. 2020;(January).
Wang L, Amin AK, Khanna P, Aali A, Mcgregor A, Bassett P, et al. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. Journal of Antimicrobial Chemotherapy. 2021;76(3):796–803.
Vijay S, Bansal N, Rao BK, Veeraraghavan B, Rodrigues C, Wattal C, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infection and Drug Resistance. 2021;14:1893–903.
Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. incidence of co-infections and super-infections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 2021;27(1):83–8.
Karami Z, Knoop BT, Dofferhoff ASM, Blaauw MJT, Janssen NA, van Apeldoorn M, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infectious Diseases [Internet]. 2021;53(2):102–10. Available from: https://doi.org/10.1080/23744235.2020.1839672
Lardaro T, Wang AZ, Bucca A, Croft A, Glober N, Holt DB, et al. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system. Journal of Medical Virology. 2021;93(5):2883–9.
Coenen S, de la Court JR, Buis DTP, Meijboom LJ, Schade RP, Visser CE, et al. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study. Antimicrobial Resistance and Infection Control [Internet]. 2021;10(1):1–10. Available from: https://doi.org/10.1186/s13756-021-01024-4
Bolker A, Coe K, Smith J, Stevenson K, Wang S, Reed E. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagnostic Microbiology and Infectious Disease. 2022;102.
Xiaojuan Zhua, Yiyue Gea, Tao Wua, Kangchen Zhaoa, Yin Chena, Bin Wua FZ, Baoli Zhua, b LC. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Research [Internet]. 2020;285:198005. Available from: https://doi.org/10.1016/j.virusres.2020.198005
Cataño-Correa JC, Cardona-Arias JA, Mancilla JPP, García MT. Bacterial super-infection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE. 2021;16(7 July):1–12.
Buehler PK, Zinkernagel AS, Hofmaenner DA, Wendel Garcia PD, Acevedo CT, Gómez-Mejia A, et al. Bacterial pulmonary super-infections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Reports Medicine. 2021;2(4).
Pan T, Chen D, Chen Y, Lin Z. Clinical Features and Risk Factors for Secondary Infection in Critically Ill Patients With COVID-19. :1–17.
Rafael Ramosa, Sofía de la Villab, Sergio García-Ramosa, Belén Padillab, Pablo García-Olivaresc, Patricia Pi˜neroa, Alberto Garridoc, Javier Hortala, Patricia Mu˜nozb, d, Estrela Caama˜noa PB. COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospital. Enfermedades Infecciosas y Microbiología Clínica. 2020;xxx(xxx):19–21.
Pickens CO, Gao CA, Cuttica MJ, Smith SB, Pesce LL, Grant RA, et al. Bacterial super-infection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. American Journal of Respiratory and Critical Care Medicine. 2021;204(8):921–32.
Battaglia CC, Hale K. Hospital-Acquired Infections in Critically Ill Patients With Cancer. Journal of Intensive Care Medicine. 2019;34(7):523–36.
Giacomo Grasselli, MD; Vittorio Scaravilli, MD; Davide Mangioni, MD; Luigia Scudeller, MD; Laura Alagna M, Michele Bartoletti, MD; Giacomo Bellani, PhD; Emanuela Biagioni, MD; Paolo Bonfanti, MD; Nicola Bottino M, Irene Coloretti, MD; Salvatore Lucio Cutuli, MD; Gennaro De Pascale, MD; Daniela Ferlicca, MD; Gabriele Fior M, Andrea Forastieri, MD; Marco Franzetti, MD; Massimiliano Greco, MD; Amedeo Guzzardella, MD; Sara Linguadoca M, Marianna Meschiari, MD; Antonio Messina, MD; Gianpaola Monti, MD; Paola Morelli, MD; Antonio Muscatello M, Simone Redaelli, MD; Flavia Stefanini, MD; Tommaso Tonetti, MD; Massimo Antonelli, MD; Maurizio Cecconi P, et al. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. CHEST. 2021;160(2):454–65.
Ramadan HKA, Mahmoud MA, Zakaria M, Aburahma, Elkhawaga AA, El-Mokhtar MA, et al. Predictors of severity and co-infection resistance profile in COVID-19 patients: First report from upper Egypt. Infection and Drug Resistance. 2020;13:3409–22.
Takwa E. Meaweda, Sherweet M. Ahmedb, Sherif M.S. Mowafyc, Ghada M. Samird RHA. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. Journal of Infection and Public Health [Internet]. 2020; Available from: https://doi.org/10.1016/j.jiph.2021.08.003
Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infectious Diseases. 2020;20(1):1–7.
Bardi T, Pintado V, Gomez-rojo M, Escudero-Sanchez R, Lopez AA, Azzam Lopez A, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. European Journal of Clinical Microbiology and Infectious Diseases [Internet]. 2021;40(3):495–502. Available from: https://www.qxmd.com/r/33389263
Manna S, Baindara P, Mandal SM. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. Journal of Infection and Public Health [Internet]. 2020;13(10):1397–404. Available from: https://doi.org/10.1016/j.jiph.2020.07.003
Paget C, Trottein F. Mechanisms of bacterial super-infection post-influenza: A role for unconventional T cells. Frontiers in Immunology. 2019;10(MAR).
Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Curr Opin Microbiol. 2017;35:30–5.
Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA. Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infection and Immunity. 2006;74(5):2562–7.
Li N, Ren A, Wang X, Fan X, Zhao Y, Gao GF, Cleary P WB. Influenza viral neuraminidase primes bacterial coinfection through TGF-beta-mediated expression of host cell receptors. Proc Natl Acad Sci U S A. 2015;112:238–42.
Ballinger MN ST. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res. 2010;30:643–52.
McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252–62.
Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME MJ. Influenzavirus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis. 2011;203(6):880–8.
Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I TE. Strep-tococcus pneumoniae anchor to activated human cells by the receptor forplatelet-activating factor. Nature. 1995;377(6548):435–8.
Pittet LA, Hall-Stoodley L, Rutkowski MR HA. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2010;42:450–60.
Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host & Microbe [Internet]. 2020;27(6):992–1000. Available from: https://doi.org/10.1038/%0As41586-020-2588-y
He Y, Li W, Wang Z, Chen H, Tian L LD. Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. nfect Control Hosp Epidemio [Internet]. 2020;41(8):982–3. Available from: https://doi.org/10.1017/ice.2020.126
Shambat SM, Gómez-Mejia A, Schweizer TA, Huemer M, Chang CC, Acevedo C, et al. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. Vol. 18, PLoS Pathogens. 2022. 1–39 p.
Peyneau M, Granger V, Wicky PH, Khelifi-Touhami D, Timsit JF, Lescure FX, et al. Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19. Scientific Reports [Internet]. 2022;12(1):1–11. Available from: https://doi.org/10.1038/s41598-021-04705-7
Nasir N, Rehman F, Omair SF. Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study. Journal of Medical Virology. 2021;93(7):4564–9.
Søvik, S.; Barratt-Due, A.; Kåsine, T.; Olasveengen, T.; Strand, M.W.; Tveita, A.A.; Berdal, J.E.; Lehre, M.A.; Lorentsen T., Heggelund L. et al. Corticosteroids and super-infections in COVID-19 patients on invasive mechanical ventilation. J Infect. 2022;85:57–63.
Zhou P et al. acterial and fungal infections in COVID-19 patients: A matter of concern. Infection Control & Hospital Epidemiology. 2020;41:1124–1125.
Hick JL BP. Novel coronavirus and old lessons—preparing the health system for the pandemic. N Engl J Med. 2020;
Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Scientific Reports [Internet]. 2021;11(1):1–8. Available from: https://doi.org/10.1038/s41598-021-92220-0
Downloads
Published
License
Copyright (c) 2023 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
